Navigation Links
IntegriChain Launches DNA: Dynamic NextGen Analytics(TM) Platform
Date:2/16/2010

PRINCETON, N.J., Feb. 16 /PRNewswire/ -- IntegriChain, Inc., a commercial insight provider supporting the pharmaceutical industry, announces the launch of its new DNA: Dynamic NextGen Analytics™ (DNA) platform. This powerful new analytic platform helps pharmaceutical manufacturers unlock the value of Direct Data through data integration, enrichment and guided analytics. Direct Data includes those data assets typically provided to the manufacturer as a function of other agreements such as fee for service, rebates, coupon programs and chargebacks.

"The pharmaceutical industry is swamped with data, both syndicated and direct. Yet answers to fundamental questions are still difficult to find. Newly emerging data sets including syndicated retail data are compounding the problem," states Kevin Leininger, IntegriChain's CEO. "Poor data quality, high cost, high latency and the historical ad-hoc nature of projects in our industry have created pressure for pharmaceutical executives. Pre-existing solutions have simply been inadequate to allow manufacturers to build a sufficient value proposition around what should be a widely leveraged, shared data asset."

IntegriChain's DNA platform has been built upon a SaaS architecture and scales to support dynamic analysis of a billion+ transaction volumes with minimal latency. The robust architecture, data warehousing and analytic capabilities of DNA can be accessed via a zero-footprint web interface, further reducing the total cost of ownership for IntegriChain's customers.

As part of the DNA: NextGen Analytics platform, IntegriChain is providing customers with a series of advanced analytical modules — DNA: Channel™, DNA: Chargeback Validation ® and DNA: Measurement of Retail Inventory™ — to maximize the value of Direct Data within mult
'/>"/>

SOURCE IntegriChain, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
4. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
7. Premier Micronutrient Launches Supplement for Hearing Health
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
11. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , September 2, 2014 ... Genetics has become the first European company to obtain ... Generation Sequencing (NGS) bioinformatic pipeline for routine genetic testing. ... in raising the standards of routine genetic testing ... Data Driven Medicine platform to a wider market. ...
(Date:9/2/2014)... Biotech Ltd. (NASDAQ: SVA ), a leading provider ... announced that the Company,s management will participate in the following ... Healthcare Conference, to be held at the Grand Hyatt New ... Stanley Asia Pacific Healthcare Day, to be held at the ... Healthcare & Technology Conference, to be held at the Wynn ...
(Date:9/2/2014)... , Sept. 2, 2014 Legal-Bay LLC, ... increase in capital and cash advance funding for ... System,s da Vinci Robot. With over 400k surgeries ... focuses on providing lawsuit cash advances for victims ... damage, lacerations to internal organs, burns to blood ...
Breaking Medicine Technology:Sophia Genetics Becomes the First European Company to Obtain CE-IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing 2Sinovac to Participate in Upcoming Investor Conferences 2da Vinci Lawsuit Settlement Funding Amounts Increased at Legal-Bay Funding 2da Vinci Lawsuit Settlement Funding Amounts Increased at Legal-Bay Funding 3
... CITY, Calif., Feb. 23, 2011 Abaxis, Inc. (Nasdaq: ... analysis systems, announced today that Clint Severson, chairman and chief ... Conference on Thursday, March 3, 2011 at 10:00 a.m. ET. ... Hotel in New York City. A live webcast ...
... Foundation and Vertex Pharmaceuticals announced today that VX-770, an oral ... cystic fibrosis, showed promising results in a Phase 3 clinical ... patients age 12 and up who carry at least one ... 161 patients who received at least one dose of VX-770 ...
Cached Medicine Technology:Abaxis, Inc. to Present at RBC Capital Markets' Healthcare Conference 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 3
(Date:9/2/2014)... (PRWEB) September 02, 2014 Lseat.com is one ... covers . All its products are user-friendly items; no professional ... original seat covers; they can slip right over the cars’ ... Now, the company’s website is filled with various kinds of ... its new designs of Jeep leather seat covers . ...
(Date:9/2/2014)... MA (PRWEB) September 02, 2014 A ... for everyone. But sometimes the onset of irritability, sadness, ... condition, reports the September 2014 Harvard Health Letter. ... response to everyday stresses. If they occur for long ... it's an indication to seek help," says Dr. Nancy ...
(Date:9/2/2014)... September 02, 2014 Researchers in New Delhi, ... developed mesothelioma after being exposed to asbestos-contaminated work clothes for ... the details of the report in a new article. ... the ESI Model Hospital say their patient was diagnosed ... Further investigation found that she had come in contact with ...
(Date:9/2/2014)... 2014 Eric Jimenez and Leah Ashley ... a revolutionary makeup application device. Designed to improve and ... in the palm of women’s hands to help them ... Color Me’s success lies in its patented technology. With ... of 15,000 pulses per minute, the device applies foundation ...
(Date:9/2/2014)... 2014 Innovations Television, produced by ... content for upcoming episodes of Innovations, focusing on ... 2015. , Innovations, hosted by Ed Begley, Jr., ... breakthroughs and advancements taking place in all areas ... advancements in biosciences. Biosciences are at the core ...
Breaking Medicine News(10 mins):Health News:High Quality 1997-2006 JEEP Wrangler TJ Leather Seat Covers From Popular Supplier Lseat.com 2Health News:When a Mood Swing Signals Trouble, From the September 2014 Harvard Health Letter 2Health News:New Report Illustrates That Even Brief Asbestos Exposure Can Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 3Health News:Exciting New Episodes of Innovations with Ed Begley Jr to Air via Discovery Channel 2
... Ill., May 13 Z Trim Holdings, Inc.,(Amex: ... statements,for the fiscal year ended December 31, 2007 contained ... accounting,firm, Blackman Kallick LLP. This announcement is being made ... which requires separate disclosure,of receipt of an audit opinion ...
... today signed three bills into law:, Senate Bill ... pharmacies, under the supervision of the State Board of,Pharmacy, ... Under the program, drugs may be returned to an ... their original packaging and the,drug expires no sooner than ...
... Company Management to discuss the benefits of Hemodiafiltration therapy and ... of Life for End-Stage Renal Disease Patients, NEW YORK, ... device company developing and marketing products designed to,improve the quality ... the critical financial and clinical needs of the care,provider, today ...
... May 13 eDiets.com,Inc. (Nasdaq: DIET ), leveraging ... healthy lifestyle solutions to everyone, today announced,results for the ... first quarter of 2008 were $8.8 million, compared to,$8.4 ... for the quarter,was $(5.1) million, or $(0.20) per diluted ...
... heres another reason to encourage your daughters to be physically ... ages of 12 and 35 have a substantially lower risk ... less active, new research shows. , In the largest ... exercise on premenopausal breast cancer, the study of nearly 65,000 ...
... underwent circulatory procedure , , TUESDAY, May 13 (HealthDay ... that the clot-preventing drug Plavix could help in the ... suitable for dialysis for kidney patients. , Giving Plavix ... would block the vessel created by combining a vein ...
Cached Medicine News:Health News:Z Trim Holdings, Inc. Audit Report Contains 'Going Concern' Qualification 2Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 2Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 3Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 4Health News:eDiets.com(R) Announces Q1 2008 Results 2Health News:eDiets.com(R) Announces Q1 2008 Results 3Health News:eDiets.com(R) Announces Q1 2008 Results 4Health News:eDiets.com(R) Announces Q1 2008 Results 5Health News:eDiets.com(R) Announces Q1 2008 Results 6Health News:Girls, young women can cut risk of early breast cancer through regular exercise 2Health News:Blood-Thinner No Help for Dialysis Treatment 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: